Degradation studies of quetiapine fumarate by liquid chromatography-diode array detection and tandem mass spectrometry methods

被引:7
作者
de Diego, Marta [1 ]
Campos, Cristobal [1 ]
Correa, Diana [1 ]
Mennickent, Sigrid [1 ]
Godoy, Ricardo [1 ]
Vergara, Carola [1 ]
机构
[1] Univ Concepcion, Dept Pharm, Fac Pharm, Concepcion, Chile
关键词
degradation products; quetiapine; stability indicating; validation; STABILITY; IDENTIFICATION; IMPURITIES; SULFOXIDE; PLASMA; DRUGS;
D O I
10.1002/bmc.4655
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Quetiapine fumarate (QUE) is an antipsychotic agent with a chemical structure that is susceptible to degradation; therefore, it is important to study its stability using appropriate analytical tools. Knowledge of the stability profile of a drug is important because chemical degradation of its active component often results in a loss of potency, affecting its efficacy and safety. This current work reports degradation studies of QUE as drug substance, under different stress conditions such as oxidation, hydrolysis, heat, humidity and photolysis, by a stability-indicating LC method. The chemical stability was evaluated using a simple HPLC/diode array detection method, with a core-shell C-18 column under isocratic conditions, which allows the separation of all primary degradation products (DPs) in a short run time. QUE was mainly degraded under oxidative and hydrolytic conditions, with the formation of three and two DPs, respectively, which were identified by electrospray ionization-tandem mass spectrometry. The method was properly validated in terms of linearity, accuracy, precision, selectivity, robustness and quantitation limit. Commercial tablets containing 25 mg of QUE were quantified, with results obtained within the United States Pharmacopeia limits. The proposed method is suitable to assess the stability and perform routine analysis of QUE in pharmaceutical samples.
引用
收藏
页数:8
相关论文
共 23 条
[1]   Quetiapine for insomnia: A review of the literature [J].
Anderson, Sarah L. ;
Griend, Joseph P. Vande .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (05) :394-402
[2]  
[Anonymous], INT C HARM ICH GUID
[3]  
Baertschi SW., 2005, PHARM STRESS TESTING, DOI [10.1201/9780849359194, DOI 10.1201/9780849359194]
[4]   Stability-indicating HPLC method for the determination of quetiapine: Application to tablets and human plasma [J].
Belal, Fathalla ;
Elbrashy, Amina ;
Eid, Manal ;
Nasr, Jenny Jeehan .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2008, 31 (09) :1283-1298
[5]   Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate [J].
Bharathi, Ch. ;
Prabahar, K. J. ;
Prasad, Ch. S. ;
Rao, M. Srinivasa ;
Trinadhachary, G. N. ;
Handa, V. K. ;
Dandala, R. ;
Naidu, A. .
PHARMAZIE, 2008, 63 (01) :14-19
[6]   A rapid LC-MS/MS method for simultaneous determination of quetiapine and duloxetine in rat plasma and its application to pharmacokinetic interaction study [J].
Chen, Xiujuan ;
Liang, Chen ;
Cui, Lijun ;
Le, Jian ;
Qian, Zheyuan ;
Zhang, Runsheng ;
Hong, Zhanying ;
Chai, Yifeng .
JOURNAL OF FOOD AND DRUG ANALYSIS, 2019, 27 (01) :323-331
[7]  
European Medicines Agency, 2003, INT C HARM GUID STAB
[8]   Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS [J].
Fisher, Danielle S. ;
Handley, Simon A. ;
Taylor, David ;
Flanagan, Robert J. .
BIOMEDICAL CHROMATOGRAPHY, 2012, 26 (09) :1125-1132
[9]   Plasma Concentrations of Quetiapine, N-Desalkylquetiapine, O-Desalkylquetiapine, 7-Hydroxyquetiapine, and Quetiapine Sulfoxide in Relation to Quetiapine Dose, Formulation, and Other Factors [J].
Fisher, Danielle S. ;
Handley, Simon A. ;
Flanagan, Robert J. ;
Taylor, David M. .
THERAPEUTIC DRUG MONITORING, 2012, 34 (04) :415-421
[10]  
ICH, 2005, INT C HARM GUID VAL